For the TB treatments of the future we need a healthy drug pipeline, adequate investment, collaboration and treatments available to all. Unfortunately, this is not the case currently.
The Life Prize aims to unite researchers to collaborate and develop a one-month (or shorter) treatment regimen for all types of TB which works for everyone, everywhere.
The Life Prize (formerly the 3P Project) advocates for the development of TB regimens of the future. This mechanism calls for the delinkage of financing of research and development (R&D) from the potential sales revenues, thus promoting access and affordability of the resulting products.